Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 599

1.

Risperidone use in children with Down syndrome, severe intellectual disability, and comorbid autistic spectrum disorders: a naturalistic study.

Capone GT, Goyal P, Grados M, Smith B, Kammann H.

J Dev Behav Pediatr. 2008 Apr;29(2):106-16. doi: 10.1097/DBP.0b013e318165c100.

PMID:
18349709
[PubMed - indexed for MEDLINE]
2.

Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.

Turgay A, Binder C, Snyder R, Fisman S.

Pediatrics. 2002 Sep;110(3):e34.

PMID:
12205284
[PubMed - indexed for MEDLINE]
3.

Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.

Research Units on Pediatric Psychopharmacology Autism Network.

Am J Psychiatry. 2005 Jul;162(7):1361-9.

PMID:
15994720
[PubMed - indexed for MEDLINE]
4.

Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence.

Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL; Risperidone Disruptive Behavior Study Group.

Am J Psychiatry. 2002 Aug;159(8):1337-46.

PMID:
12153826
[PubMed - indexed for MEDLINE]
5.

Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs.

Snyder R, Turgay A, Aman M, Binder C, Fisman S, Carroll A; Risperidone Conduct Study Group.

J Am Acad Child Adolesc Psychiatry. 2002 Sep;41(9):1026-36.

PMID:
12218423
[PubMed - indexed for MEDLINE]
6.

Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.

Aman MG, Binder C, Turgay A.

J Child Adolesc Psychopharmacol. 2004 Summer;14(2):243-54.

PMID:
15319021
[PubMed - indexed for MEDLINE]
7.

Autistic-spectrum disorders in Down syndrome: further delineation and distinction from other behavioral abnormalities.

Carter JC, Capone GT, Gray RM, Cox CS, Kaufmann WE.

Am J Med Genet B Neuropsychiatr Genet. 2007 Jan 5;144B(1):87-94.

PMID:
16958028
[PubMed - indexed for MEDLINE]
8.

Down syndrome and comorbid autism-spectrum disorder: characterization using the aberrant behavior checklist.

Capone GT, Grados MA, Kaufmann WE, Bernad-Ripoll S, Jewell A.

Am J Med Genet A. 2005 May 1;134(4):373-80.

PMID:
15759262
[PubMed - indexed for MEDLINE]
9.

Long-term effects of risperidone in children with autism spectrum disorders: a placebo discontinuation study.

Troost PW, Lahuis BE, Steenhuis MP, Ketelaars CE, Buitelaar JK, van Engeland H, Scahill L, Minderaa RB, Hoekstra PJ.

J Am Acad Child Adolesc Psychiatry. 2005 Nov;44(11):1137-44.

PMID:
16239862
[PubMed - indexed for MEDLINE]
10.

A crossover study of risperidone in children, adolescents and adults with mental retardation.

Hellings JA, Zarcone JR, Reese RM, Valdovinos MG, Marquis JG, Fleming KK, Schroeder SR.

J Autism Dev Disord. 2006 Apr;36(3):401-11.

PMID:
16596465
[PubMed - indexed for MEDLINE]
11.

Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ.

Findling RL, Aman MG, Eerdekens M, Derivan A, Lyons B; Risperidone Disruptive Behavior Study Group.

Am J Psychiatry. 2004 Apr;161(4):677-84.

PMID:
15056514
[PubMed - indexed for MEDLINE]
12.

Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.

Santosh PJ, Baird G, Pityaratstian N, Tavare E, Gringras P.

Child Care Health Dev. 2006 Sep;32(5):575-83.

PMID:
16919137
[PubMed - indexed for MEDLINE]
13.

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.

Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F.

Pediatrics. 2004 Nov;114(5):e634-41. Epub 2004 Oct 18.

PMID:
15492353
[PubMed - indexed for MEDLINE]
14.

Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications.

Gagliano A, Germanò E, Pustorino G, Impallomeni C, D'Arrigo C, Calamoneri F, Spina E.

J Child Adolesc Psychopharmacol. 2004 Spring;14(1):39-47.

PMID:
15142390
[PubMed - indexed for MEDLINE]
15.

A naturalistic open-label study of mirtazapine in autistic and other pervasive developmental disorders.

Posey DJ, Guenin KD, Kohn AE, Swiezy NB, McDougle CJ.

J Child Adolesc Psychopharmacol. 2001 Fall;11(3):267-77.

PMID:
11642476
[PubMed - indexed for MEDLINE]
16.

Use of risperidone in a paediatric population: an observational study.

King B, Zwi K, Nunn K, Longworth J, Dossetor D.

J Paediatr Child Health. 2003 Sep-Oct;39(7):523-7.

PMID:
12969207
[PubMed - indexed for MEDLINE]
17.

Treating disruptive behavior disorders with risperidone: a 1-year, open-label safety study in children and adolescents.

Haas M, Karcher K, Pandina GJ.

J Child Adolesc Psychopharmacol. 2008 Aug;18(4):337-45. doi: 10.1089/cap.2007.0098.

PMID:
18759643
[PubMed - indexed for MEDLINE]
18.

Risperidone in children with disruptive behavior disorders and subaverage intelligence: a 1-year, open-label study of 504 patients.

Croonenberghs J, Fegert JM, Findling RL, De Smedt G, Van Dongen S; Risperidone Disruptive Behavior Study Group.

J Am Acad Child Adolesc Psychiatry. 2005 Jan;44(1):64-72.

PMID:
15608545
[PubMed - indexed for MEDLINE]
19.

A naturalistic study of predictors and risks of atypical antipsychotic use in an attention-deficit/hyperactivity disorder clinic.

Weiss M, Panagiotopoulos C, Giles L, Gibbins C, Kuzeljevic B, Davidson J, Harrison R.

J Child Adolesc Psychopharmacol. 2009 Oct;19(5):575-82. doi: 10.1089/cap.2009.0050.

PMID:
19877982
[PubMed - indexed for MEDLINE]
20.

Comparison of long-term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder. An open label maintenance study.

Gencer O, Emiroglu FN, Miral S, Baykara B, Baykara A, Dirik E.

Eur Child Adolesc Psychiatry. 2008 Jun;17(4):217-25.

PMID:
18026891
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk